# BioMonde Larval Debridement Therapy Products-Larvae 100/200/300 BioMonde Larval Debridement Therapy Products-Larvae 100/200/300 (K123449) Larval Debridement Therapy Products-Larvae 100/200/300 (K123449) (BK251214)

_Biomonde (A Trading name of Zoobiotic Limited) · Mar 5, 2013 · SESE_

**Canonical URL:** https://fda-staging.innolitics.com/device/BK251214

## Device Facts

- **Applicant:** Biomonde (A Trading name of Zoobiotic Limited)
- **Decision Date:** Mar 5, 2013
- **Decision:** SESE

---

**Source:** [https://fda-staging.innolitics.com/device/BK251214](https://fda-staging.innolitics.com/device/BK251214)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com